Significant Accounting Policies [Text Block] | 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of business and basis of presentation National Research Corporation, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations in the United States and Canada. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth. The Company’s six one six The condensed consolidated balance sheet of the Company at December 31, 2017, Information and footnote disclosures included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto that are included in the Company’s Form 10 December 31, 2017, March 14, 2018. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, National Research Corporation Canada, doing business as NRC Health Canada. All significant intercompany transactions and balances have been eliminated. The Company’s Canadian subsidiary uses as its functional currency the local currency of the country in which it operates. It translates its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. It translates its revenue and expenses at the average exchange rate during the period. The Company includes translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. Gains and losses related to transactions denominated in a currency other than the functional currency of the country in which the Company operates and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income. Revenue Recognition On January 1, 2018, 2014 09, Revenue- Revenue from Contracts with Customers 606” January 1, 2018 January 1, 2018 606, not $2.7 $814,000 The Company derives a majority of its revenues from its annually renewable subscription-based service agreements with its customers, which include performance measurement and improvement services, healthcare analytics and governance education services. Such agreements are generally cancelable on short or no 3 606, ● Identify the contract, or contracts, with a customer ● Identify the performance obligations in the contract ● Determine the transaction price ● Allocate the transaction price to the identified performance obligations ● Recognize revenue when, or as, the Company satisfies the performance obligations. The Company’s revenue arrangements with a client may one may one one not Prior to 2018, third not not The Company’s arrangements with customers consist principally of four 1 2 one 3 4 Subscription-based services - twelve may One-time services – one Fixed, non-subscription services – 2018, Unit-price services – The Company recognizes contract assets or unbilled receivables related to revenue recognized for services completed but not The following tables summarize the impact the adoption of ASC 606 Consolidated balance sheet: As reported June 30, 2018 Adjustments Balances without Adoption of ASC 606 Accounts receivable, net $ 10,689 $ 5 $ 10,694 Other current assets 125 (72 ) 53 All other current assets 12,819 -- 12,819 Total current assets 23,633 (67 ) 23,566 Deferred contract costs 3,369 (3,369 ) -- All other noncurrent assets 75,883 -- 75,883 Total assets $ 102,885 $ (3,436 ) $ 99,449 Deferred revenue $ 16,660 $ 61 $ 16,721 Other current liabilities 16,257 -- 16,257 Total current liabilities 32,917 61 32,978 Deferred income taxes 5,808 (802 ) 5,006 Other long term liabilities 37,343 -- 37,343 Total liabilities 76,068 (741 ) 75,327 Retained earnings (99,810 ) (2,697 ) (102,507 ) Accumulated other comprehensive income (2,333 ) 2 (2,331 ) Other stockholders’ equity 128,960 -- 128,960 Total stockholders’ equity 26,817 (2,695 ) 24,122 Total liabilities and stockholders’ equity $ 102,885 $ (3,436 ) $ 99,449 Consolidated statement of income: Three months ended June 30, 2018 Six months ended June 30, 2018 As reported Adjustments Balances Without Adoption of ASC 606 As reported Adjustments Balances Without Adoption of ASC 606 Revenue $ 28,017 $ 120 $ 28,137 $ 59,034 $ 48 $ 59,082 Direct expenses 10,996 (28 ) 10,968 23,904 (59 ) 23,845 Selling, general and administrative 7,940 (173 ) 7,767 15,808 57 15,865 Depreciation and amortization 1,325 -- 1,325 2,608 -- 2,608 Total operating expenses 20,261 (201 ) 20,060 42,320 (2 ) 42,318 Operating income 7,756 321 8,077 16,714 50 16,764 Other income (expense) 63 -- 63 71 -- 71 Income before income taxes 7,819 321 8,140 16,785 50 16,835 Provision (benefit) for income taxes (129 ) 74 (55 ) 1,531 12 1,543 Net income $ 7,948 $ 247 $ 8,195 $ 15,254 $ 38 $ 15,292 Earnings per share of common stock: Basic earnings per share: Common (formerly Class A) $ 0.29 $ 0.01 $ 0.30 $ 0.47 $ -- $ 0.47 Class B 0.27 -- 0.27 1.31 -- 1.31 Diluted earnings per share: Common (formerly Class A) $ 0.28 $ 0.01 $ 0.29 $ 0.45 $ -- $ 0.45 Class B 0.26 0.01 0.27 1.27 0.01 1.28 Consolidated statement of comprehensive income: Three months ended June 30, 2018 Six months ended June 30, 2018 As reported Adjustments Balances without adoption of ASC 606 As reported Adjustments Balances without adoption of ASC 606 Net Income $ 7,948 $ 247 $ 8,195 $ 15,254 $ 38 $ 15,292 Cumulative translation adjustment (283 ) 4 (279 ) (698 ) 2 (696 ) Comprehensive Income $ 7,665 $ 251 $ 7,916 $ 14,556 $ 40 $ 14,596 Consolidated statement of cash flows: Six months ended June 30, 2018 As reported Adjustments Balances without adoption of ASC 606 Cash flows from operating activities: Net income $ 15,254 $ 38 $ 15,292 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 2,608 -- 2,608 Deferred income taxes 996 12 1,008 Reserve for uncertain tax positions 92 -- 92 Non-cash share-based compensation expense 995 -- 995 Impairment of property and equipment 2 -- 2 Change in assets and liabilities: Trade accounts receivable and unbilled revenue 3,955 128 4,083 Prepaid expenses and other current assets (2,393 ) (2 ) (2,395 ) Deferred contract costs 2 (2 ) -- Accounts payable 481 -- 481 Accrued expenses, wages, bonus and profit sharing (2,371 ) -- (2,371 ) Income taxes receivable and payable (1,235 ) -- (1,235 ) Deferred revenue 5 (176 ) (171 ) Net cash provided by operating activities 18,391 (2 ) 18,389 Net cash used in investing activities (2,773 ) -- (2,773 ) Net cash used in financing activities (43,058 ) -- (43,058 ) Effect of exchange rate changes on cash (595 ) 2 (593 ) Change in cash and cash equivalents (28,035 ) -- (28,035 ) Cash and cash equivalents at beginning of period 34,733 -- 34,733 Cash and cash equivalents at end of period $ 6,698 -- $ 6,698 Deferred Contract Costs Deferred contract costs, net is stated at gross deferred costs less accumulated amortization. Beginning January 1, 2018, three five $445,000 $1,272,000 three six June 30, 2018, $639,000 $1,254,000 three six June 30, 2018, $29,000 $59,000 three six June 30, 2018, $610,000 $1,195,000 three six June 30, 2018, $7,000 $19,000 three six June 30, 2018, one 2018, January 1, 2018 $2.6 $776,000 $3.4 2018, Fair Value Measurements The Company’s valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect the Company’s market assumptions. The inputs are then classified into the following hierarchy: ( 1 1 2 2 1 not 3 3 Commercial paper and Eurodollar deposits are included in cash equivalents and are valued at amortized cost, which approximates fair value due to their short-term nature. Eurodollar deposits are United States dollars deposited in a foreign bank branch of a United States bank and have daily liquidity. Both of these are included as a Level 2 The following details the Company’s financial assets and liabilities within the fair value hierarchy at June 30, 2018 December 31, 2017: Fair Values Measured on a Recurring Basis Level 1 Level 2 Level 3 Total (In thousands) As of June 30, 2018 Money Market Funds $ 767 $ -- $ -- $ 767 Total $ 767 $ -- $ -- $ 767 As of December 31, 2017 Money Market Funds $ 13,971 $ -- $ -- $ 13,971 Commercial Paper -- 10,490 -- 10,490 Eurodollar Deposits -- 10,017 -- 10,017 Total $ 13,971 $ 20,507 $ -- $ 34,478 There were no three June 30, 2018. The Company's long-term debt is recorded at historical cost. The fair value of long-term debt is classified in Level 2 June 30, 2018 December 31, 2017 (In thousands) Total carrying amount of long-term debt $ 39,781 $ 1,067 Estimated fair value of long-term debt $ 39,813 $ 1,066 The Company believes that the carrying amounts of trade accounts receivable, accounts payable and accrued expenses approximate their fair value due to the short maturity of those instruments. Long-lived assets that are not June 30, 2018, December 31, 2017, no Contingencies Since the September 2017 2 three three Gennaro v. National Research Corporation, et al November 15, 2017, Gerson v. Hays, et al November 16, 2017. In re National Research Corporation Shareholder Litigation third Apfel v. Hays, et al December 1, 2017. In re National Research Corporation Shareholder Litigation March 23, 2018 Apfel April 4, 2018 June 30, 2018, no not Recent Accounting Pronouncements Not In January 2016, 2016 01, 2016 01 2016 01 December 15, 2017, not not In February 2016, 2016 02, 842 twelve December 15, 2018, June 30, 2018, $4.0 not not not In June 2016, 2016 13, 326 December 15, 2019 not |